JERUSALEM (AP) _ Oramed Pharmaceuticals Inc. (ORMP) on Thursday reported a loss of $2.5 million in its fiscal first quarter.
The Jerusalem-based company said it had a loss of 18 cents per share.
The drug maker posted revenue of $611,000 in the period.
Oramed shares have decreased 2 percent since the beginning of the year. The stock has risen 35 percent in the last 12 months.